Search Results
Search for other papers by Marie Plourde in
Google Scholar
PubMed
Search for other papers by Caroline Manhes in
Google Scholar
PubMed
Search for other papers by Gilles Leblanc in
Google Scholar
PubMed
Search for other papers by Francine Durocher in
Google Scholar
PubMed
Search for other papers by Martine Dumont in
Google Scholar
PubMed
Search for other papers by Olga Sinilnikova in
Google Scholar
PubMed
Search for other papers by INHERIT BRCAs in
Google Scholar
PubMed
Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada
Search for other papers by Jacques Simard in
Google Scholar
PubMed
Introduction Most of the familial aggregation in breast cancer results predominantly from inherited susceptibility ( Lichtenstein et al . 2000 , Peto & Mack 2000 ). Germline mutations in high-penetrance cancer susceptibility genes such as breast
Search for other papers by Ankita Agrawal in
Google Scholar
PubMed
Search for other papers by Alison Gartland in
Google Scholar
PubMed
people at a greater risk of developing diseases and bone disorders. P2X7R and bone cancer Bone tissue provides a fertile setting for cancer cells and is a common metastatic site owing to this microenvironment. Signalling mechanisms involving purines and
Search for other papers by F M Fioretti in
Google Scholar
PubMed
Search for other papers by A Sita-Lumsden in
Google Scholar
PubMed
Search for other papers by C L Bevan in
Google Scholar
PubMed
Androgen Signalling Laboratory, Molecular Oncology, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK
Search for other papers by G N Brooke in
Google Scholar
PubMed
Breast cancer Breast cancers (BCs) account for one in three newly diagnosed cases of cancer in women and led to 11 600 deaths in 2010 in the UK alone ( CRUK 2014 ). Incidence rates increased by 90% between 1971 and 2010, with the largest increase in
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Search for other papers by Irene I Lee in
Google Scholar
PubMed
Search for other papers by Nane C Kuznik in
Google Scholar
PubMed
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Search for other papers by Jaice T Rottenberg in
Google Scholar
PubMed
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Search for other papers by Myles Brown in
Google Scholar
PubMed
Search for other papers by Andrew C B Cato in
Google Scholar
PubMed
experimentally tested. BAG1L and prostate cancer The regulation of AR activity by BAG1L and the driver role of the AR in prostate cancer progression has generated an interest in the action of BAG1L in prostate cancer. A link between BAG1L and prostate
Breast Cancer Now Research Centre, Institute of Cancer Research, London, UK
Search for other papers by Cathrin Brisken in
Google Scholar
PubMed
Search for other papers by Valentina Scabia in
Google Scholar
PubMed
Introduction A woman’s risk to get breast cancer is affected by her reproductive history and hence exposure to reproductive hormones. An early full-term pregnancy has protective effects ( MacMahon et al. , 1970 ), whereas risk increases with
Search for other papers by Dagmara Rusinek in
Google Scholar
PubMed
Search for other papers by Sylwia Szpak-Ulczok in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Introduction Gene expression profiling of thyroid tumors has expanded our knowledge of the molecular biology of thyroid cancer. Several recent reviews addressed the biological and diagnostic aspects of microarray-based studies of thyroid cancer
Search for other papers by Ali Salajegheh in
Google Scholar
PubMed
Search for other papers by Haleh Vosgha in
Google Scholar
PubMed
Search for other papers by Atiqur Md Rahman in
Google Scholar
PubMed
Search for other papers by Moein Amin in
Google Scholar
PubMed
Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia
Search for other papers by Robert Anthony Smith in
Google Scholar
PubMed
Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia
Search for other papers by Alfred King-Yin Lam in
Google Scholar
PubMed
-205 can repress cancer proliferation, clonogenic survival, growth and aggressiveness by direct targeting of related genes such as E2F1 and BCl2 ( Vosgha et al . 2014 ). Nonetheless, the role of this miRNA has not been investigated in the
Search for other papers by James F H Pittaway in
Google Scholar
PubMed
Search for other papers by Leonardo Guasti in
Google Scholar
PubMed
expression maintains an undifferentiated phenotype and promotes clonogenicity, findings suggestive of cancer stem cell-like functionality ( Kim et al. 2009 ). In the rat adrenal cortex, Dlk1 is co-expressed with Shh cells in the ZU ( Guasti et al. 2013
Search for other papers by Amy R Dwyer in
Google Scholar
PubMed
Search for other papers by Thu H Truong in
Google Scholar
PubMed
Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA
Search for other papers by Julie H Ostrander in
Google Scholar
PubMed
Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA
Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA
Search for other papers by Carol A Lange in
Google Scholar
PubMed
cancer subtypes. However, increasing studies have implicated differential PR isoform expression in the etiology of breast cancer ( Mote et al. 2002 , 2015 , Rojas et al. 2017 , Lamb et al. 2018 ). Furthermore, PRs dramatically influence ER
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
Search for other papers by Adrien Georges in
Google Scholar
PubMed
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
Search for other papers by Aurelie Auguste in
Google Scholar
PubMed
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
Search for other papers by Laurianne Bessière in
Google Scholar
PubMed
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
Search for other papers by Anne Vanet in
Google Scholar
PubMed
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
Search for other papers by Anne-Laure Todeschini in
Google Scholar
PubMed
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
Search for other papers by Reiner A Veitia in
Google Scholar
PubMed
role in late folliculogenesis. For example, FOXL2 overexpression in GCT-derived cells causes induction of prostaglandin synthase (or COX2), but it has also been showed that it could repress the induction of this gene by ESR1 in breast cancer or